Company
Vanda Pharmaceuticals
113 Legal Matters
21
54
38

Vanda Pharmaceuticals Company IP Overview

Practice Areas
Recent StatisticsView All
Subscription-Only
View Concierge Program
PatentsView All
Patents Issued Each Year
TrademarksView All
Trademark Applications Filed Each Year
LitigationView All
Cases Filed Each Year
Pedram Sameni
Patexia Insight 195: Lateral Moves of CAFC Attorneys in 2023
Pedram Sameni
Dec 7, 2023
  In late October, we unveiled the CAFC Intelligence Report 2023, a comprehensive analysis encompassing stakeholders before the Court of... Read More
Pedram Sameni
Patexia Insight 152: Best Performing Brand and Generic Pharmas of 2022 (ANDA)
Pedram Sameni
Sep 22, 2022
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More
Warren Woessner
Solicitor General’s Briefs Encourage Supreme Court to Put s. 101 Back on Track
Warren Woessner
Dec 10, 2019
Earlier this year, the Supreme Court issued orders to the Solicitor General to weigh in on whether or not the... Read More
Practice Areas
PatentsView All
Patents Issued Each Year
LitigationView All
Cases Filed Each Year
Recent StatisticsView All
Subscription-Only
View Concierge Program
TrademarksView All
Trademark Applications Filed Each Year
Pedram Sameni
Patexia Insight 195: Lateral Moves of CAFC Attorneys in 2023
Pedram Sameni
Dec 7, 2023
  In late October, we unveiled the CAFC Intelligence Report 2023, a comprehensive analysis encompassing stakeholders before the Court of... Read More
Pedram Sameni
Patexia Insight 152: Best Performing Brand and Generic Pharmas of 2022 (ANDA)
Pedram Sameni
Sep 22, 2022
Last month, we released our third annual ANDA Litigation Intelligence Report evaluating all stakeholders in ANDA/Hatch-Waxman cases filed over the... Read More
Warren Woessner
Solicitor General’s Briefs Encourage Supreme Court to Put s. 101 Back on Track
Warren Woessner
Dec 10, 2019
Earlier this year, the Supreme Court issued orders to the Solicitor General to weigh in on whether or not the... Read More